Airway gene transfer using cationic emulsion as a mucosal gene carrier

Area of Science:

• Biotechnology
• Gene Therapy
• Nanomedicine

Background:

• Gene delivery to airway mucosa is crucial for gene therapy and vaccination.
• Limited effective gene delivery systems exist for mucosal administration.
• Cationic emulsions offer a stable and efficient alternative for gene transfer.

Purpose of the Study:

• To evaluate cationic emulsions as a novel gene delivery system for airway mucosa.
• To compare the efficacy of cationic emulsions with liposomes for gene transfection.
• To assess the stability and protective capabilities of cationic emulsions in the presence of mucosal components.

Main Methods:

• Formulation of cationic lipid emulsions using squalene and DOTAP.
• Complexation of DNA with cationic emulsions and assessment of stability against DNase I.
• In vitro testing in the presence of mucosal destabilizers (heparin sulfate, Newfectan).
• In vivo intranasal instillation and evaluation of transfection activity in nasal and lung tissues.

Main Results:

• Cationic emulsions formed stable complexes with DNA, protecting it from degradation.
• Emulsions demonstrated superior DNA protection and transfer compared to liposomes in vitro.
• In vivo studies showed over 200-fold higher transfection activity for cationic emulsions in nasal and lung tissues.
• Cationic emulsions effectively mediated gene transfection against mucosal destabilizers.

Conclusions:

• Cationic emulsions are effective carriers for gene transfection into airway epithelium.
• This system holds significant potential for therapeutic gene delivery and genetic vaccination via the airway route.
• Cationic emulsions represent a promising advancement in mucosal gene delivery technology.